Fordays Announces Patent Acquisition for 'Oxidized Protein Repair Agent and Oxidative Stress Inhibitor via Protein Repair'

Key facts

  • Fordays Announces Patent Acquisition for 'Oxidized Protein Repair Agent and Oxidative Stress Inhibitor via Protein Repair'
  • Fordays Co., Ltd. has acquired a patent (No. 7857645) for an oxidized protein repair agent using salmon milt extract. Human clinical trials confirmed that intake of the extract increases the expression of the methionine sulfoxide reductase A (MSRA) gene and reduces blood oxidative stress (d-ROMs), suggesting potential for mitigating aging-related oxidative stress.
  • Source: PR Times
  • Date: June 2, 2026

Direct answer

Fordays Co., Ltd. has acquired a patent (No. 7857645) for an oxidized protein repair agent using salmon milt extract. Human clinical trials confirmed that intake of the extract increases the expression of the methionine sulfoxide reductase A (MSRA) gene and reduces blood oxidative stress (d-ROMs), suggesting potential for mitigating aging-related oxidative stress.

Citation
Fordays Announces Patent Acquisition for 'Oxidized Protein Repair Agent and Oxidative Stress Inhibitor via Protein Repair' (June 2, 2026), PR Times
Source
PR Times
Date
June 2, 2026
Fordays Co., Ltd. has acquired a patent (No. 7857645) for an oxidized protein repair agent using salmon milt extract. Human clinical trials confirmed that intake of the extract increases the expression of the methionine sulfoxide reductase A (MSRA) gene and reduces blood oxidative stress (d-ROMs), suggesting potential for mitigating aging-related oxidative stress.
businessNQ 53/100出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: June 2, 2026 at 22:00
  • 🔍 Collected: June 2, 2026 at 13:20
  • 🤖 AI Analyzed: June 2, 2026 at 13:22 (1 min after Collected)
Fordays Co., Ltd., a seller of nucleic acid-based health foods and cosmetics, is pleased to announce the acquisition of a patent for an 'Oxidized Protein Repair Agent and Oxidative Stress Inhibitor via Protein Repair.' The patent number is 7857645. Oxidative stress, caused by reactive oxygen species, damages DNA and proteins, leading to cellular dysfunction and aging. Methionine, a key amino acid, is particularly susceptible to oxidation. In human trials, subjects consuming tablets containing salmon milt extract for eight weeks showed increased expression of the methionine sulfoxide reductase A (MSRA) gene and a significant reduction in blood d-ROMs (oxidative stress levels). These results suggest that the repair mechanism of oxidized proteins contributes to the reduction of oxidative stress. Fordays remains committed to researching nucleic acid nutrition to support health and longevity.

FAQ

Do Taiwanese consumers value patents in health products?

Yes, products backed by scientific evidence and clinical trial data are highly regarded in the Taiwanese market.

What are the key facts in this article?

Fordays Co., Ltd. has acquired a patent (No. 7857645) for an oxidized protein repair agent using salmon milt extract. Human clinical trials confirmed that intake of the extract increases the expression of the methionine sulfoxide reductase A (MSRA) gene and reduces blood oxidative stress (d-ROMs), suggesting potential for mitigating aging-related oxidative stress.

What is the direct answer?

Fordays Co., Ltd. has acquired a patent (No. 7857645) for an oxidized protein repair agent using salmon milt extract. Human clinical trials confirmed that intake of the extract increases the expression of the methionine sulfoxide reductase A (MSRA) gene and reduces blood oxidative stress (d-ROMs), suggesting potential for mitigating aging-related oxidative stress.

Back to Newsroom (4)